Navellier & Associates Inc Simulations Plus, Inc. Transaction History

Navellier & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$32.91 - $59.82 $512,803 - $932,115	-15,582 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$26.79 - $38.99 $23,575 - $34,311	-880 Reduced 5.35%	15,582 $544,000
Q4 2019 Feb 12, 2020	BUY	$29.07 - $35.63 $45,494 - $55,760	1,565 Added 10.51%	16,462 $479,000
Q3 2019 Oct 16, 2019	BUY	$28.19 - $41.75 $419,946 - $621,949	14,897 New	14,897 $517,000

180

15.9M

3.9K

200

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $650M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.